SKYE Sale Disclosure
Schwab Andrew J. · SEC Form 4 · Filed Sep 18, 2026
Sale
Calculated transaction value
$2.45K
Schwab Andrew J. Director / Ten Percent Owner
SKYE
Skye Bioscience
SKYE
Transaction date
Sep 16, 2026
Public filing date
Sep 18, 2026
Filing lag
Filed 2 days later
SKYE daily price context
Close on/before transaction
$1.7
Sep 16, 2026
Close before public filing
$1.57
Sep 17, 2026
Return since public filing
+10.83%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,285 shares @ $1.91
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001598549-26-000013
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$64.73K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Skye Bioscience, Inc. SKYE Current | Sale | Sep 16, 2026 | $2.45K |
| Skye Bioscience, Inc. SKYE | Sale | Sep 16, 2026 | $62.28K |